Playing 1/8
  • Your Brain On Fentanyl (FIXED)

    YouTube 03:45
  • Synthesis and applications of Tramadol - ORGANIC CHEMISTRY IN INDUSTRY

    YouTube 01:56
  • This is your brain on heroin

    YouTube 01:52
  • A New Paradigm for Buprenorphine Testing

    YouTube 59:33
  • CINV: The Role of NK1 Receptor Antagonists

    YouTube 04:55
  • 2-Minute Neuroscience: Opioids

    YouTube 02:00
  • Mu Opioid Receptor Splicing and Signaling: Another Dimension of GPCR Function

    YouTube 57:42
  • Pain Recruits the Kappa Opioid System to Drive Negative Affect

    YouTube 04:13

BU09059 is a potent, selective, short-acting (non-"inactivating") antagonist of the κ-opioid receptor (KOR). It was derived from the irreversible (long-acting) KOR antagonist JDTic in search of an antagonist with a reversible profile of inactivation of the KOR that could be used with less concern to treat psychiatric disorders. In addition to its reversibility, BU09059 is much more selective for the KOR than JDTic, showing 15-fold and 616-fold preference for the KOR over the μ- and δ-opioid receptors.

Discover in context

This site is not available in the landscape mode.
Please rotate your phone or install our app.